Allergan Pharmaceuticals Ireland have announced up to 200 new jobs at its Westport plant today. The positions will further its development and manufacturing of BOTOX® (botulinum toxin type A) by investing $350 million (€270 million) in the expansion of its site. The pleased IDA CEO Barry O’Leary today said: “In addition to excellence in manufacturing and consistent with IDA strategy, the Westport site has increased its involvement in the late stage development of new products. “This announcement is a welcome endorsement of Ireland’s record with the Development and Manufacturing model and represents a further boost for the vibrant pharma chemical sector here.
